 Home > Active Ingredient News > Antitumor Therapy > Targeting HER2 antibody drug conjugateENHERTU for breast cancer, gets quick review by the European Medicines Agency

Targeting HER2 antibody drug conjugateENHERTU for breast cancer, gets quick review by the European Medicines Agency

 Last Update: 2020-07-14
 Source: Internet
 Author: User

Tags

what diuretic drug

duloxetine drug class

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Daiichi/AstraZeneca, Inc.,an antibody drug conjugate dating her2 ENHERTU (FAM-traszumab deruxtecan-nxki) for the treatment ofbreast cancerand obtained an accelerated review by the European DrugAdministrationBureau (EMA)The drug was approved by the U.SFood and Drug Administration (
FDA) in December to treat patients with HER2-positive metastatic breast cancer who have previously received two or more treatments based on the anti-HER2 regimenFDA approval and THE EMA's accelerated review are based on data from the DESTINY-Breast01 trial, which evaluated ENHERTU in patients previously treated with Herceptin, Perjeta, or KadcylaThe results showed that ENHERTU reached an objective mitigation rate of 60%, including more than 4% of total mitigation, and the median mitigation period was 14.8 monthsAZ reached a $6.9 billion cooperation agreement with Daiichi in March last year to commercialize ENHERTUanalysts predict edited that AZ/Daiichi's drug could replace Kadcyla as a multibillion-dollar drug with sales of up to $12 billion

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.